Imagen de Portada

Mechanism of Musashi2 affecting radiosensitivity of lung cancer by modulating DNA damage repair

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Hongjin Qu, Xiong Shi, Ying Xu, Hongran Qin, Junshi Li, Shanlin Cai, Jianpeng Zhao, Bingbing Wan, Yanyong Yang, Bailong Li
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	MedComm
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Targeting the DNA damage response in cancer
por: Federica Guffanti, et al.
Publicado: (2024)

CircMALAT1 promotes cancer stem‐like properties and chemoresistance via regulating Musashi‐2/c‐Myc axis in esophageal squamous cell carcinoma
por: Zitong Zhao, et al.
Publicado: (2024)

Gallium complex K6 inhibits colorectal cancer by increasing ROS levels to induce DNA damage and enhance phosphatase and tensin homolog activity
por: Wei Li, et al.
Publicado: (2024)

Dual homologous recombinase‐mediated lineage tracing technique: New insights for lung stem cell repair
por: Yujiao Wu, et al.
Publicado: (2024)

The SUMOylated RREB1 interacts with KDM1A to induce 5‐fluorouracil resistance via upregulating thymidylate synthase and activating DNA damage response pathway in colorectal cancer
por: Ya‐Nan Deng, et al.
Publicado: (2025)

The combination of tumor mutational burden and T‐cell receptor repertoire predicts the response to immunotherapy in patients with advanced non–small cell lung cancer
por: Yalun Li, et al.
Publicado: (2024)

Comprehensive multi‐omics analysis provides biological insights and therapeutic strategies for small‐cell lung cancer
por: Guo Zhao, et al.
Publicado: (2024)

Robust tetra‐armed poly (ethylene glycol)‐based hydrogel as tissue bioadhesive for the efficient repair of meniscus tears
por: Jing Ye, et al.
Publicado: (2024)

New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
por: Sha Qin, et al.
Publicado: (2024)

Perioperative immunotherapy: the main clinical treatment for resectable non‐small cell lung cancer
por: Zhijun Yuan, et al.
Publicado: (2024)

Differential expression of the MYC‐Notch axis drives divergent responses to the front‐line therapy in central and peripheral extensive‐stage small‐cell lung cancer
por: Libo Luo, et al.
Publicado: (2025)

Changes in L‐phenylalanine concentration reflect and predict response to anti‐PD‐1 treatment combined with chemotherapy in patients with non‐small cell lung cancer
por: Yaqing Liu, et al.
Publicado: (2025)

RNA modifications in cancer
por: Han Wu, et al.
Publicado: (2025)

Macrophage plasticity: signaling pathways, tissue repair, and regeneration
por: Lingfeng Yan, et al.
Publicado: (2024)

Genome‐scale CRISPR–Cas9 screen identifies PAICS as a therapeutic target for EGFR wild‐type non‐small cell lung cancer
por: Yufeng Li, et al.
Publicado: (2024)

Phase 1b trial of anti‐HER2 antibody inetetamab and pan‐HER inhibitor pyrotinib in HER2‐positive advanced lung cancer
por: Yihua Huang, et al.
Publicado: (2024)

Epithelial Atg5 Deficiency Intensifies Caspase‐11 Activation, Fueling Extracellular mtDNA Release to Activate cGAS–STING–NLRP3 Axis in Macrophages During Pseudomonas Infection
por: Junyi Wang, et al.
Publicado: (2025)

Renal cancer: signaling pathways and advances in targeted therapies
por: Aimin Jiang, et al.
Publicado: (2024)

Influence of TP53 mutation on efficacy and survival in advanced EGFR‐mutant non‐small cell lung cancer patients treated with third‐generation EGFR tyrosine kinase inhibitors
por: Zhonghan Zhang, et al.
Publicado: (2024)

Liver Fibrosis: Molecular Pathogenesis and Therapeutic Interventions
por: Jiaorong Qu, et al.
Publicado: (2026)

Controlled release of MIF siRNA and GDNF protein from a photocurable scaffold efficiently repairs spinal cord injury
por: Yan Gao, et al.
Publicado: (2025)

Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non‐small cell lung cancer: a multi‐institutional retrospective cohort study
por: Leilei Wu, et al.
Publicado: (2024)

Patient‐derived xenograft model in cancer: establishment and applications
por: Ao Gu, et al.
Publicado: (2025)

Critical roles and clinical perspectives of RNA methylation in cancer
por: Ganglei Li, et al.
Publicado: (2024)

Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study
por: Zheng Liu, et al.
Publicado: (2025)

Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
por: Shiqi Li, et al.
Publicado: (2024)

Liposome‐based in situ antigen‐modification strategy for “universal” T‐cell‐receptor engineered T cell in cancer immunotherapy
por: Qin Wang, et al.
Publicado: (2024)

Natural killer cells in cancer immunotherapy
por: DanRu Wang, et al.
Publicado: (2024)

Stable Expressed DNMT3A Mutants Predict a Poor Prognosis in Acute Myeloid Leukemia Patients Without Receiving Hematopoietic Stem Cell Transplantation
por: Xiang Zhang, et al.
Publicado: (2025)

Breast Cancer: Molecular Pathogenesis, Targeted Therapy, Screening, and Prevention
por: Huijun Lei, et al.
Publicado: (2026)

Genome‐Wide 5‐Methylcytosine and 5‐Hydroxymethylcytosine Signatures Analysis of Plasma Cell‐Free DNA in Schizophrenia
por: Gang Xue, et al.
Publicado: (2025)

Dual Targeting of DNA and EGFR by ZYH005 Induces DNA Damage and Mitotic Catastrophe in Glioblastoma
por: Jianzheng Huang, et al.
Publicado: (2026)

Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies
por: Jun He, et al.
Publicado: (2024)

Dimethyl fumarate alleviate hepatic ischemia–reperfusion injury through suppressing cGAS‐STING signaling
por: Yi Xiong, et al.
Publicado: (2025)

Cellular senescence in cancer: molecular mechanisms and therapeutic targets
por: Ping Jin, et al.
Publicado: (2024)

Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications
por: Siyu Wang, et al.
Publicado: (2024)

Targeting RNA‐binding motif protein 39 for arginine reduction: unveiling metabolic vulnerability in arginine‐dependent liver cancer
por: Aoxue Li, et al.
Publicado: (2024)

NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2/PD‐L1‐dependent manner
por: Jiwei Zhang, et al.
Publicado: (2024)

Inhibition of Selenoprotein I promotes ferroptosis and reverses resistance to platinum chemotherapy by impairing Akt phosphorylation in ovarian cancer
por: Jing Li, et al.
Publicado: (2024)

Detection of Epstein‒Barr virus DNA methylation as tumor markers of nasopharyngeal carcinoma patients in saliva, oropharyngeal swab, oral swab, and mouthwash
por: Xiao‐Hui Zheng, et al.
Publicado: (2024)